ANG-MAB (AngioChem)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameANG-MAB (AngioChem)

Drug Alias NameANG-MAB (AngioChem)anti-EGFR antibody/AngioPep conjugate (AngioChem)anti-VEGF antibody/AngioPep conjugate (AngioChem)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionVascular endothelial growth factor receptor antagonistsEpidermal growth factor receptor erbB1 antagonists

TargetsVascular endothelial growth factor receptorEpidermal growth factor receptor erbB1

Therapy Area/IndicationsBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAngiochem Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAngiochem Inc

Active IndicationsN/A

Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A